Progressive Myopia in Children: Treatment Options
Understanding Progressive Myopia in Your Child
Progressive myopia means your child's nearsightedness is getting worse over time. Each year, your child's eye doctor measures a stronger prescription, and your child has increasing difficulty seeing distant objects clearly. This progression happens because the eyeball continues to grow longer than normal during childhood.
Most children's myopia progresses from the time it first appears, often between ages 6 and 12, until the late teens or early twenties when eye growth stabilizes. The earlier myopia starts, the more years it has to progress, which can lead to high myopia by adulthood.
Higher myopia is not just a matter of thicker glasses. Children who reach high myopia carry a greater lifetime risk for retinal detachment, glaucoma, and macular degeneration, conditions that can cause permanent vision loss in adulthood. No treatment available today reverses existing myopia, so slowing progression during childhood is the most effective strategy.
According to the AAO, earlier intervention, before or at early myopia onset, yields the greatest long-term benefit from myopia control treatments. If your child's prescription is increasing, discussing treatment options with your eye doctor now can make a meaningful difference in your child's future eye health.
Children with one or both parents who are nearsighted have a higher risk of developing progressive myopia. Limited outdoor time, extended close-range activities like reading and screen use, and myopia that starts before age 8 are all associated with faster progression.
Your child's eye doctor evaluates these risk factors alongside annual exam measurements. If your child's prescription is changing rapidly, typically more than half a diopter per year, your doctor may recommend active myopia management rather than just updating the glasses prescription.
FDA-Approved Treatments for Children
MiSight 1 day lenses are the first FDA-approved soft contact lens for myopia control in children. They are approved for children ages 8 to 12 at the start of treatment. A three-year clinical trial showed a 59% reduction in myopia progression compared to standard daily contact lenses (FDA/AAO).
Your child wears MiSight lenses during the day and throws them away each evening. The daily disposable design means your child starts with a fresh, sterile lens each morning, which reduces infection risk compared to reusable contacts. Your child still sees clearly for distance while the lens works to slow eye growth.
Specialized spectacle lenses received FDA marketing authorization in 2022 for children ages 6 to 12. Clinical data showed these lenses slow myopia progression by 71% on average over two years (FDA, 2022). Your child wears them as everyday glasses, with no special handling or hygiene routine.
Myopia control glasses are the simplest treatment option for young children or those who are not ready for contact lenses. The lenses look and feel like regular glasses. Your child's eye doctor measures and fits the lenses specifically for your child's prescription and eye anatomy.
A pharmaceutical-grade low-dose atropine formulation (SYD-101) has an FDA action date of October 23, 2025 (Sydnexis, March 2025). If approved, it would be the first FDA-approved drug specifically indicated for pediatric myopia progression in the United States. Currently, eye doctors prescribe compounded atropine off-label for this purpose.
The potential approval of an FDA-approved atropine product would give families a standardized, quality-controlled treatment option. Your child's eye doctor can explain the current off-label approach and how an FDA-approved product may change the options available to your family.
Other Proven Treatment Options
Low-dose atropine drops are applied to your child's eyes once at bedtime. About 90% of children respond to treatment, with studies showing roughly a 50% reduction in progression rate (AAO). Doses range from 0.01% to 0.05%. Higher doses slow progression more but cause more side effects like light sensitivity.
Your child's eye doctor starts with a lower concentration and adjusts based on your child's response and tolerance. The nightly drop takes seconds to administer. Treatment continues as long as myopia is progressing, typically through the teenage years.
Ortho-K uses custom rigid lenses worn only during sleep. Overnight, the lenses gently reshape your child's cornea. In the morning, your child removes the lenses and sees clearly all day without glasses or contacts. Research shows ortho-K reduces eye elongation by up to 50% (AAO).
Ortho-K suits children who are active in sports and want freedom from daytime eyewear. Because the lenses are worn overnight, a parent helps with insertion and removal at bedtime and in the morning. Strict hygiene is required to reduce infection risk from overnight lens wear.
A two-year study found that combining low-dose atropine with ortho-K contact lenses was 28% to 38% more effective than either treatment alone (AAO). Your child's eye doctor may recommend combination therapy if a single treatment is not slowing progression enough.
Combination therapy means managing two treatments at once: nightly contact lens wear plus a daily eye drop. This adds complexity to your child's routine but may provide better results for rapid progressors who need aggressive management.
The Protective Role of Outdoor Time
Children who spend at least two hours per day outdoors show delayed myopia onset and slower progression. Bright natural light triggers dopamine release in the retina, which appears to slow the axial elongation that drives myopia (AAO/NEI). This effect comes from light intensity, not from looking at distant objects.
Even cloudy days provide more light than indoor environments. Your child does not need direct sunlight to benefit. Encourage outdoor play, sports, and activities during daylight hours.
Outdoor time supplements clinical treatments. A child using atropine drops or myopia control lenses who also spends two hours outside daily may see better results than treatment alone. The two approaches work through different mechanisms and can add to each other.
If your family's schedule limits outdoor time during the week, make up for it on weekends. Any increase in outdoor exposure helps, even if reaching the full two hours daily is not always possible.
Monitoring Your Child's Myopia
Your child's eye doctor measures the prescription (refractive error) and may also measure axial length (the physical length of the eyeball). Axial length is the most direct indicator of whether treatment is slowing eye growth. A device called an optical biometer measures axial length in seconds without touching your child's eye.
Regular monitoring, typically every 6 to 12 months, shows whether the treatment is working. If progression continues despite treatment, your doctor adjusts the approach, perhaps increasing the atropine dose or adding a second treatment.
Myopia management continues as long as your child's eyes are growing and the prescription is changing. Most children stabilize in the late teens to early twenties. Your eye doctor may gradually reduce or stop treatment once measurements show stability over two or more visits.
After treatment ends, your child continues wearing glasses or contacts to correct existing myopia. The treatment did not eliminate nearsightedness; it limited how severe it became. Your child transitions to standard vision correction for adulthood.
Questions Parents Ask About Progressive Myopia
Treatment can begin as soon as progression is documented. Myopia control glasses work for children as young as 6. Contact lens options like MiSight are approved for ages 8 to 12 at initiation. Atropine drops can be used at any age. Your eye doctor recommends a specific approach based on your child's age and maturity.
Myopia control contacts are used during childhood while eyes are still growing. Once your child's prescription stabilizes, typically in the late teens, they can switch to standard glasses or contacts, or consider surgery as an adult. The myopia control lenses are a temporary treatment phase, not a lifelong commitment.
You may notice your child squinting more, holding books closer, sitting nearer to screens, or complaining about blurry distance vision. Annual eye exams with prescription measurements are the reliable way to track progression. If your child's prescription changes at each visit, discuss myopia management with your eye doctor.
Ortho-K lenses are safe when fitted by an experienced eye doctor and used with strict hygiene. Because they are worn during sleep, they carry a higher infection risk than daily disposable lenses. Parent involvement in the nightly routine, including lens cleaning and storage, reduces that risk. Your eye doctor monitors your child's corneal health at regular follow-up visits.
Extended near work, including screen time, is associated with myopia risk. Reducing close-range activities may help, but outdoor time has stronger evidence for slowing progression than screen time reduction alone. Balance screen limits with increased outdoor activity for the best overall approach.
Costs vary by treatment type. Myopia control glasses have a one-time lens cost similar to standard glasses. Atropine drops require a prescription and pharmacy costs. Specialty contacts carry ongoing supply and fitting fees. Ask your eye doctor about all options, including whether your insurance covers any portion. Starting with the most affordable option is better than waiting.
Protect Your Child's Long-Term Vision
Talk to your child's eye doctor about myopia management at the next exam. Early treatment offers the greatest benefit in limiting your child's final degree of nearsightedness and reducing the risk of complications in adulthood.